{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:04Z","timestamp":1791295624364,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.lpm.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T08:16:28Z","timestamp":1408004188000},"page":"957-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypertension art\u00e9rielle pulmonaire des connectivites"],"prefix":"10.1016","volume":"43","author":[{"given":"Paul","family":"Legendre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a025","key":"10.1016\/j.lpm.2014.07.009_bib0005","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/berh.2000.0086","article-title":"The spectrum of inflammatory rheumatic disorders","volume":"14","author":"Walker-Bone","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatol Oxf Engl"},{"issue":"7","key":"10.1016\/j.lpm.2014.07.009_bib0025","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.lpm.2014.07.009_bib0030","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0035","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.lpm.2014.07.009_bib0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.07.009_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.lpm.2014.07.009_bib0050","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and meta-analysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2008.091710","article-title":"Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study","volume":"68","author":"Vonk","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.lpm.2014.07.009_bib0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","article-title":"Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis","volume":"39","author":"Phung","year":"2009","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0070","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0075","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.07.009_bib0080","doi-asserted-by":"crossref","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the reveal registry","author":"Chung","year":"2014","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.lpm.2014.07.009_bib0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0090","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1378\/chest.124.6.2098","article-title":"Age and risk of pulmonary arterial hypertension in scleroderma","volume":"124","author":"Schachna","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2014.07.009_bib0100","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis-associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.lpm.2014.07.009_bib0120","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0125","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1186\/ar4124","article-title":"KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor","volume":"14","author":"Bossini-Castillo","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0130","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"126","key":"10.1016\/j.lpm.2014.07.009_bib0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1183\/09059180.00005112","article-title":"Early detection and management of pulmonary arterial hypertension","volume":"21","author":"Humbert","year":"2012","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.110987","article-title":"Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease","volume":"39","author":"Rajaram","year":"2012","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.lpm.2014.07.009_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0160","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.lpm.2014.07.009_bib0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.revmed.2011.01.002","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus","volume":"32","author":"Arnaud","year":"2011","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.lpm.2014.07.009_bib0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0961203308098361","article-title":"An update in pulmonary hypertension in systemic lupus erythematosus: do we need to know about it?","volume":"18","author":"Minai","year":"2009","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0175","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lpm.2014.07.009_bib0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0185","first-page":"328","article-title":"Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-5231(05)70113-1","article-title":"Respiratory complications in mixed connective tissue disease","volume":"19","author":"Prakash","year":"1998","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.lpm.2014.07.009_bib0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-857X(05)70335-5","article-title":"Pulmonary hypertension in systemic autoimmune disease","volume":"23","author":"Gurubhagavatula","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.lpm.2014.07.009_bib0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-3083.2006.01770.x","article-title":"Clinical and immunoserological characteristics of mixed connective tissue disease-associated with pulmonary arterial hypertension","volume":"64","author":"Vegh","year":"2006","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome in a French multiracial\/multi-ethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.lpm.2014.07.009_bib0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary Sj\u00f6gren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"Launay","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0733-8651(18)30514-9","article-title":"The pathophysiology and management of primary pulmonary hypertension","volume":"5","author":"Fein","year":"1987","journal-title":"Cardiol Clin"},{"issue":"1","key":"10.1016\/j.lpm.2014.07.009_bib0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.lpm.2014.07.009_bib0230","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0235","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1183\/09031936.00039212","article-title":"Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension","volume":"41","author":"Henkens","year":"2013","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous \u00e9poprost\u00e9nol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.lpm.2014.07.009_bib0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ahj.2008.10.029","article-title":"Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review","volume":"157","author":"Oudiz","year":"2009","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.lpm.2014.07.009_bib0250","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension*: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest J"},{"key":"10.1016\/j.lpm.2014.07.009_bib0255","series-title":"Selexipag meets primary endpoint in pivotal Phase III GRIPHON outcome study in patients with pulmonary arterial hypertension","year":"2014"},{"issue":"1","key":"10.1016\/j.lpm.2014.07.009_bib0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.124.1.247","article-title":"Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study","volume":"124","author":"Sitbon","year":"2003","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0265","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","article-title":"Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases","volume":"67","author":"Denton","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.lpm.2014.07.009_bib0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.medcli.2013.01.042","article-title":"Hepatotoxicity in patients treated with endothelin receptor antagonists: systematic review and meta-analysis of randomized clinical trials","volume":"142","author":"Mac\u00edas Saint-Gerons","year":"2014","journal-title":"Med Cl\u00ednica"},{"issue":"7","key":"10.1016\/j.lpm.2014.07.009_bib0275","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.101262","article-title":"Expert agreement on EULAR\/EUSTAR recommendations for the management of systemic sclerosis","volume":"38","author":"Walker","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0280","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.lpm.2014.07.009_bib0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1755-5922.2011.00279.x","article-title":"ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension","volume":"30","author":"Badesch","year":"2012","journal-title":"Cardiovasc Ther"},{"issue":"23","key":"10.1016\/j.lpm.2014.07.009_bib0290","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lpm.2014.07.009_bib0295","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.lpm.2014.07.009_bib0300","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.lpm.2014.07.009_bib0305","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lpm.2014.07.009_bib0310","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/ard.2007.077149","article-title":"Effects of oral treatments on exercise capacity in systemic sclerosis-related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.lpm.2014.07.009_bib0315","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMc051946","article-title":"Imatinib for the treatment of pulmonary arterial hypertension","volume":"353","author":"Ghofrani","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lpm.2014.07.009_bib0320","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lpm.2014.07.009_bib0325","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0033-1356494","article-title":"Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?","volume":"34","author":"Godinas","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.lpm.2014.07.009_bib0330","first-page":"2268","article-title":"Riociguat for pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.lpm.2014.07.009_bib0335","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.lpm.2014.07.009_bib0340","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.lpm.2014.07.009_bib0345","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1253\/circj.CJ-11-0473","article-title":"Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"75","author":"Miyamichi-Yamamoto","year":"2011","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.lpm.2014.07.009_bib0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lpm.2014.07.009_bib0355","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/art.22264","article-title":"Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension","volume":"54","author":"Schachna","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.07.009_bib0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2014.01.020","article-title":"Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13\u00a0patients, review of the literature and position paper of a multidisciplinary Working Group","author":"Launay","year":"2014","journal-title":"Presse Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:27:16Z","timestamp":1565735236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0755498214003637"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.009","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension art\u00e9rielle pulmonaire des connectivites","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}